The role of ophthalmologists in the opioid epidemicAn observational cohort study, published in JAMA Ophthalmology, used Medicare Part D data to assess the number of opioid prescriptions written by ophthalmologists in the United States.
NACDS Endorses Improvements to Drug Monitoring ProgramsNACDS is supporting the MONITOR Act to help curb opioid abuse.
Community Pharmacists Praise New Opioid Measures
Community Pharmacists Praise New Opioid MeasuresIn the war against the opioid epidemic, pharmacists are excited about their seat at the table.
FDA Plans to Expand Access to Certain OpioidsCommissioner Scott Gottlieb makes a departure from previous policy.
McKesson Supports Opioid Limits
McKesson Supports Opioid LimitsAnother large company pledges its support for helping to fight the opioid epidemic.
Two Companies Announce Drug RecallsTwo companies have issued recalls on their products.
Program uses provider, patient incentives to fight opioid epidemicProviders are coming up short when it comes to HEDIS measures related to substance abuse. Here’s how one health plan is changing that.
Study: Patients combine toxic medications with ‘alarming frequency’A new study uses population health analytics to identify potential opioid abuse, and the study findings are troubling.
The Other Side of Opioid Limits
The Other Side of Opioid LimitsProponents argue that limits reduce the risk of addiction, but are they keeping pharmacists from caring for their patients?
FDA Shuts Down Fake PharmaciesA worldwide operation shuts down hundreds of illegal websites.